CERCAM (cerebral endothelial cell adhesion molecule) has a low cancer specificity, has been detected in all cancer tissues and is known as an unfavorable prognostic marker in renal cancer, urothelial cancer and ovarian cancer [33]. This evidence concerns the gene CERCAM and ovarian cancer.